Clinical Trials Directory

Trials / Conditions / Adult Lymphocyte Predominant Hodgkin Lymphoma

Adult Lymphocyte Predominant Hodgkin Lymphoma

8 registered clinical trials studyying Adult Lymphocyte Predominant Hodgkin Lymphoma.

StatusTrialSponsorPhase
CompletedCPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lym
NCT02168140
Wake Forest University Health SciencesPhase 1
CompletedGemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT01535924
Beth ChristianPhase 1 / Phase 2
UnknownBrentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II
NCT01476410
Northwestern UniversityPhase 2
CompletedA Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT01460940
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedBortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Re
NCT00381940
National Cancer Institute (NCI)Phase 2
CompletedSGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT00337194
National Cancer Institute (NCI)Phase 2
TerminatedFlavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
NCT00112723
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedVorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma
NCT00132028
National Cancer Institute (NCI)Phase 2